These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38844271)
1. Potential predictive value of immune-related genes FUCA1 and NCKAP1L for osteosarcoma metastasis. Wang X; Dou J; Liu M; Zhang Y; Li Y; Tong Z Gene; 2024 Nov; 927():148645. PubMed ID: 38844271 [TBL] [Abstract][Full Text] [Related]
2. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis. Shi S; Zhang L; Guo X Front Immunol; 2024; 15():1424950. PubMed ID: 39108264 [TBL] [Abstract][Full Text] [Related]
4. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer. Liu R; Hu Y; Liu T; Wang Y BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489 [TBL] [Abstract][Full Text] [Related]
5. Single-cell RNA sequencing reveals the communications between tumor microenvironment components and tumor metastasis in osteosarcoma. Li J; Bai Y; Zhang H; Chen T; Shang G Front Immunol; 2024; 15():1445555. PubMed ID: 39324133 [TBL] [Abstract][Full Text] [Related]
6. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. He L; Yang H; Huang J BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089 [TBL] [Abstract][Full Text] [Related]
7. Infiltration of LPAR5 He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H Front Immunol; 2022; 13():909932. PubMed ID: 36591220 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients. Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645 [TBL] [Abstract][Full Text] [Related]
9. Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma. Liu D; Hu Z; Jiang J; Zhang J; Hu C; Huang J; Wei Q Sci Rep; 2022 Jan; 12(1):1617. PubMed ID: 35102149 [TBL] [Abstract][Full Text] [Related]
10. Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma. Lu Y; Cao N; Zhao M; Zhang G; Zhang Q; Wang L Sci Rep; 2024 Apr; 14(1):9769. PubMed ID: 38684858 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma. Li Q; Huang X; Zhao Y Cancer Biother Radiopharm; 2024 Sep; 39(7):502-516. PubMed ID: 37889617 [No Abstract] [Full Text] [Related]
12. Prognositic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma. Wang D; Deng Q; Peng Y; Tong Z; Li Z; Huang L; Zeng J; Li J; Miao J; Chen S Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 May; 49(5):758-774. PubMed ID: 39174890 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the effects of M2 macrophage-derived PDE4C on the prognosis, metastasis and immunotherapy benefit of osteosarcoma. Pan F; Pan R; Hu R; Zhang H; Lei S; Zhang L; Zhou C; Zeng Z; Tian X; Xie Q J Cell Mol Med; 2024 May; 28(10):e18395. PubMed ID: 38774995 [TBL] [Abstract][Full Text] [Related]
14. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes. Ligon JA; Choi W; Cojocaru G; Fu W; Hsiue EH; Oke TF; Siegel N; Fong MH; Ladle B; Pratilas CA; Morris CD; Levin A; Rhee DS; Meyer CF; Tam AJ; Blosser R; Thompson ED; Suru A; McConkey D; Housseau F; Anders R; Pardoll DM; Llosa N J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021032 [TBL] [Abstract][Full Text] [Related]
15. Development of a Risk Model and Genotyping Patterns Based on Disulfidptosis-Related lncRNAs to Predict Prognosis and Immune Landscape in Osteosarcoma. Zhang K; Lu S; Jiang M; Zou X; Chen C; Lan Y; Zhao H; Ma R; Yan H Front Biosci (Landmark Ed); 2024 May; 29(5):193. PubMed ID: 38812298 [TBL] [Abstract][Full Text] [Related]
16. A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children. Jiang F; Miao XL; Zhang XT; Yan F; Mao Y; Wu CY; Zhou GP J Immunol Res; 2021; 2021():5523832. PubMed ID: 34337075 [TBL] [Abstract][Full Text] [Related]
17. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma. Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497 [TBL] [Abstract][Full Text] [Related]
18. PDE1B, a potential biomarker associated with tumor microenvironment and clinical prognostic significance in osteosarcoma. Chen Q; Xing C; Zhang Q; Du Z; Kong J; Qian Z Sci Rep; 2024 Jun; 14(1):13790. PubMed ID: 38877061 [TBL] [Abstract][Full Text] [Related]
19. Identification of TNFRSF1A as a potential biomarker for osteosarcoma. Zhang Y; Liu K; Wang J Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759 [TBL] [Abstract][Full Text] [Related]
20. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma. Yang H; Zhao L; Zhang Y; Li FF Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]